This site is intended for health professionals only
Wednesday 26 October 2016 Instagram
Share |

Inhaled insulin: a diabetes innovation

Inhaled insulin: a diabetes innovation


Inhaled insulin (Exubera; Pfizer) was launched in the UK in August 2006. It is a dry-powdered, human, regular insulin that is made into an aerosol mechanically by a handheld device at the time of inhalation. The powder is prepackaged in 1mg and 3mg foil packets that deliver the equivalent of around three and eight units of insulin. The large surface area of the lung enables the large insulin molecule to cross from the alveoli by transcytosis. It is then released and taken up by endothelial cells to be released into the bloodstream.

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?